Biomark Diagnostics (BUX) News Today → Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars (From GoldenCrest Metals) (Ad) Free BUX Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBlackRock Allocation Target Shrs Ser A (BATAX)finance.yahoo.com - April 20 at 10:28 PMBioMark Announces Warrant Extension and Granting of Optionsfinance.yahoo.com - April 18 at 10:50 AMBioMark to Advance Development of Cancer Treatment for Glioblastomafinance.yahoo.com - April 9 at 1:30 PMBioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communitiesfinance.yahoo.com - February 28 at 9:43 AMTheresa Peterson Joins Biomark's Advisory Teamfinance.yahoo.com - February 26 at 10:52 AMQuest Diagnosticsfortune.com - February 20 at 12:41 PMBioMark Diagnostics, Inc.: BioMark Announces Closing of $1.9 Million Non-Brokered Private Placementfinanznachrichten.de - December 29 at 8:43 AMBioMark Announces Closing of $1.9 Million Non-Brokered Private Placementfinance.yahoo.com - December 29 at 8:43 AMBioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assaymarkets.businessinsider.com - December 4 at 10:31 AMBioMark Diagnostics, Inc.: BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Termfinanznachrichten.de - November 28 at 9:32 AMBioMark Strengthens and Expands Its Strategic Advisory Team in Pursuit of Commercialization Initiativesfinance.yahoo.com - November 14 at 10:38 AMBioMark to Unveil Results of Its Early Breast Cancer Study at the Upcoming San Antonio Breast Cancer Symposiumfinance.yahoo.com - October 24 at 9:39 AMBioMark Appoints Kevin J. Cosgriff to Its Strategic Advisory Teamfinance.yahoo.com - August 30 at 9:52 AMJapan Patent Office (JPO) Issued BioMark Patent with Claims Covering Its Lung Cancer Urine Based Liquid Biopsy Assayfinance.yahoo.com - August 8 at 11:21 AMBioMark Diagnostics, Inc.: BioMark Issues Statement on Recent Market Activity and Provides a Brief Corporate Updatefinanznachrichten.de - July 25 at 11:41 AMBioMark Issues Statement on Recent Market Activity and Provides a Brief Corporate Updatefinance.yahoo.com - July 25 at 11:41 AMGary Lineker and ex-stepdaughter Ella Bux put on a smiley display at Wimbledonmirror.co.uk - July 17 at 7:55 AMBioMark Unveils Significant Scientific Advancements from Its Leading Liquid Biopsy Technology at ASCO 2023 Annual Meetingfinance.yahoo.com - June 5 at 10:16 AMBioMark Announces the U.S. Patent and Trademark Office Granted Patent with Claims Covering Its Lung Cancer Liquid Biopsy Assayfinance.yahoo.com - May 31 at 9:45 AMLiver Cancer Diagnostic Tests Market to Witness Huge Growth with Abbott Diagnostics, Abcodia, BioMark Technologies, AXO Science SASmarketwatch.com - May 5 at 9:30 AMBioMark Latest Results Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 2023markets.businessinsider.com - May 3 at 12:27 PMCanadian Cancer Diagnostic Company BioMark Working On Early Lung Detection Assaymsn.com - April 10 at 8:38 PMBioMark Diagnostics, Inc.: BioMark Presents Novel Liquid Biopsy Data in Pulmonary Neuroendocrine Tumorsfinanznachrichten.de - March 16 at 10:25 AMBioMark Presents Novel Liquid Biopsy Data in Pulmonary Neuroendocrine Tumorsfinance.yahoo.com - March 16 at 10:25 AMBioMark Diagnostics, Inc.: BioMark Provides Third Quarter Operational Update and 2023 Outlookfinanznachrichten.de - March 1 at 10:05 AMBioMark Provides Third Quarter Operational Update and 2023 Outlookfinance.yahoo.com - March 1 at 10:05 AMBioMark Diagnostics Inc.barrons.com - January 15 at 12:10 PMBioMark Announces Update from Ongoing Clinical Trial Using Its Lung Cancer Liquid Biopsy Test as It Prepares for Commercial Launchca.finance.yahoo.com - January 11 at 6:40 PMBioMark Provides Business Update and Second Quarter Financial Resultsfinance.yahoo.com - November 28 at 5:09 PMBioMark's Glioblastoma Study Published in Cancers Demonstrates Inhibiting SAT1 Sensitized Cancer Cells Towards Radiation and Chemotherapyfinance.yahoo.com - October 27 at 9:13 AMThe US Patent Office Grants BioMark Additional Patent for Its Liquid Biopsy Technologyfinance.yahoo.com - September 20 at 4:35 PMBioMark Diagnostics Inc. (BUX.CN)ca.finance.yahoo.com - September 9 at 11:25 PMBioMark to Present Validation Data of Its Multianalyte Metabolite Panel for Lung Cancer Screening at the ESMO Congress 2022finance.yahoo.com - September 8 at 10:07 AMBioMark Selected by the Medical Alley and Investissement Quebec to Join the Us Go-To-Market Acceleratorfinance.yahoo.com - September 1 at 12:37 PMBioMark Provides First-Quarter 2022 Financial Results and Operational Updatefinance.yahoo.com - August 30 at 1:50 PMBioMark Continues to Strengthen Its Intellectual Property Position with New Patent and Trademark Use in Canadafinance.yahoo.com - June 21 at 11:06 AMBioMark Diagnostics and the Icahn School of Medicine at Mount Sinai Announce Partnership to Advance Early Lung Cancer Screening Technologyfinance.yahoo.com - June 7 at 12:19 PMBioMark Announces Closing of $1,5 Million Financing Round to Accelerate Commercialization of Its Liquid Biopsy Technologyfinance.yahoo.com - May 4 at 9:17 AMAs NJ plastic bag ban looms, here's everything you need to know to handle the changeyahoo.com - April 29 at 9:09 PMStocks in play: BioMark Diagnostics Incca.finance.yahoo.com - April 27 at 3:10 PMBioMark to Present New Cancer Screening Data Using the LDTD-MS/MS Technique at the Annual ASMS Conference on Mass Spectrometrystockhouse.com - April 27 at 3:10 PMBioMark Provides the Third Quarter Operational Update and 2022 Outlookstockhouse.com - March 1 at 8:09 PMBioMark to Present at the Virtual Biotech Showcase and the Digital RESI JPM 2022 Conferencesfinance.yahoo.com - January 10 at 9:37 AMBioMark to Collaborate with Astrazeneca, Pfizer Canada and The IUCPQ Foundation in a $3.5m Project to Improve Early Detection of Lung Cancerfinance.yahoo.com - November 30 at 1:08 PMBioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Termfinance.yahoo.com - November 25 at 10:31 AMBioMark Secures Funding to Accelerate Development of Its Liquid Biopsy Assay in Quebecstockhouse.com - November 16 at 2:20 PMBioMark Recognizes and Supports the Lung Cancer Awareness Monthfinance.yahoo.com - November 10 at 12:19 PMDiagnostic and Therapeutic Benefits of BioMark's Cancer Marker Featured in Two Poster Presentations at the Canadian Cancer Research Conferencefinance.yahoo.com - November 8 at 10:51 AMBioMark Diagnostics Inc (BUX)investing.com - October 23 at 7:48 AMStarbucks customer shares how to get ‘free refills’ while shopping at Targetyahoo.com - August 20 at 6:16 AM Get Biomark Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BUX and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars (Ad)Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver. Learn More Now BUX Media Mentions By Week BUX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BUX News Sentiment▼0.660.44▲Average Medical News Sentiment BUX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BUX Articles This Week▼40▲BUX Articles Average Week Get Biomark Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BUX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DCNN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CNSX:BUX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingElon Musk’s Controversial New Project: “Apollo”InvestorPlaceBiden out June 13; Kamala won’t replace him?Paradigm PressNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomark Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
